NAIC Accounting Update: 2026 Spring National Meeting
Introduction
On March 23, 2026, as part of the National Association of Insurance Commissioners
(NAIC) 2026 Spring National Meeting held on March 21–25, 2026, in San Diego,
California, the Statutory Accounting Principles (E) Working Group (SAPWG) met to
continue work on its focus areas. SAPWG is the working group within the NAIC that
maintains revisions to the NAIC’s Accounting Practices and Procedures Manual
(the “AP&P Manual”). The AP&P Manual contains guidance for insurers on
preparing financial statements for financial regulation purposes.
Notably, this was the first SAPWG meeting in 12 years at which Dale Bruggeman of the
Ohio Department of Insurance did not serve as chair. Kevin Clark of the Iowa
Department of Insurance and Financial Services stepped into the chair role, with Mr.
Bruggeman taking the role of vice chair.
This Insurance Spotlight highlights key statutory accounting topics discussed
by SAPWG at the NAIC 2026 Spring National Meeting. For a comprehensive list of SAPWG
agenda items that were adopted, exposed for public comment, deferred, or otherwise
addressed during the event, see pages 17 through 26 of Deloitte’s NAIC Update: 2026 Spring National Meeting.
Asset Liability Management Derivatives
Asset liability management (ALM) derivatives are interest rate hedging instruments
that hedge the duration difference of the designated asset and liability portfolios.
These hedging programs are commonly used in the insurance industry for various risk
mitigation purposes (e.g., to manage asset portfolios associated with a liability
target duration). However, these programs could not meet the criteria for
establishing a highly effective hedge under the current accounting frameworks in
SSAP No. 861 or SSAP No. 108,2 causing volatility since the hedges are marked to market in surplus.
This issue was further brought to the forefront by the work of the
Interest Maintenance Reserve (IMR) Ad Hoc Subgroup of SAPWG (see the Interest Maintenance Reserve section for further
discussion). Regulators found that some insurers were deferring gains and losses
from “economically effective” ALM derivatives even though those derivatives did not
meet the criteria for establishing a highly effective hedge under SSAP No. 86,
creating inconsistency in statutory reporting.
In response, industry representatives proposed a new statutory accounting framework
specifically for ALM derivatives used to hedge asset liability duration mismatches
driven by interest rate sensitivity — an activity viewed as central to protecting
insurer surplus. After several years of discussion, SAPWG released an exposure draft of SSAP No. 1093 and a draft issue paper to incorporate new statutory accounting
guidance applicable to ALM hedging programs.
Under proposed SSAP No. 109, the hedging derivatives would be reported at amortized
cost. When those derivatives are terminated or dedesignated, the derivative fair
value would be deferred and amortized into income over a period not to exceed 10
years, and the deferred balance would qualify for admittance and recognition on the
statutory balance sheet. An amount equal to the net deferred asset and deferred
liability would be allocated from unassigned funds to special surplus. Hedge
effectiveness would be tested by analyzing the durations of the designated asset and
liability portfolios and comparing the impact of the hedging program on the
difference.
Notably, proposed SSAP No. 109 would prevent the use of derivatives with asymmetrical
payoff profiles or premiums at inception (e.g., options). Further, the proposal
would require (1) the insurer to obtain explicit approval by the domiciliary state
and (2) a financial officer to certify that the ALM hedging program is part of a
formal “Clearly Defined Hedging Strategy.”
Proposed disclosure requirements include a narrative description of each ALM hedging
program and quantitative information about the hedging instruments and the deferred
assets and liabilities, as well as expanded disclosures in the event of terminations
or ineffectiveness.
The exposure draft of SSAP No. 109 states that its proposed guidance would become
effective on January 1, 2027, and would be applied on a prospective basis. However,
the exposure draft also includes a one-time transition provision for approved, open
qualifying programs to reclassify recognized unrealized gains and losses from
derivative fair value changes to deferred assets and deferred liabilities.
The exposure draft is expected to be adopted at the NAIC Summer National Meeting in
August 2026. Insurers will need to monitor the final adoption for any changes.
Further, life insurers will need to reevaluate existing ALM hedging programs to
determine whether hedge accounting can be achieved under the new guidance in SSAP
No. 109, with a special focus on documentation, financial reporting, and internal
controls.
Interest Maintenance Reserve
After the NAIC 2026 Spring National Meeting, the IMR Ad Hoc
Subgroup of SAPWG achieved its goal of substantively revising SSAP No. 7.4 The draft revised SSAP No. 75 and a draft issue paper were exposed on April 20, 2026.
At the NAIC 2026 Spring National Meeting, SAPWG continued to consider certain matters
that the Ad Hoc Subgroup had brought up for discussion, as highlighted below.
Agenda Item 2025-23
Agenda Item 2025-23 was adopted and updates SSAP No. 7 to
include specific proof of reinvestment templates for those insurers with a net
negative IMR balance. Net negative IMR is admissible under INT 23-01,6 subject to certain limitations.
A core premise underlying the admission of a net negative IMR is that realized
losses on sold fixed-income securities may be deferred only when the related
sale proceeds are reinvested in newly acquired fixed-income securities at higher
yields. To support this determination, the proposal includes a prescribed
calculation template to evaluate (1) whether the insurer has acquired a
sufficient volume of fixed-income investments relative to investable premiums
and sold fixed-income securities and (2) whether the weighted-average yield on
acquired investments exceeds that of the investments sold. An insurer is
required to satisfy both conditions to move from a prior positive IMR position
to a current net negative IMR balance, or to further increase an existing net
negative IMR balance.
Although the calculations are operationally complex, they are intended to be
formulaic, drawing primarily from existing annual statement captions.
While Agenda Item 2025-23 was technically adopted by SAPWG, the adoption was
meant only to approve the concepts for inclusion in the revised SSAP No. 7.
SAPWG directed NAIC staff to continue to work with industry representatives to
refine the templates.
Agenda Item 2025-22
Agenda Item 2025-22 exposes revisions to SSAP No. 617 to clarify how IMR that is eliminated as part of a reinsurance transaction
should influence the reinsurance collateral that is required for the cedent to
receive reinsurance credit.
The principal issue is whether negative IMR derecognized in a reinsurance
transaction should reduce the associated collateral requirement from an
unauthorized or certified reinsurer. Industry participants have advocated for
symmetrical treatment, under which derecognized positive IMR would increase
required collateral and derecognized negative IMR would reduce it, on the basis
that ceded reserves together with IMR more appropriately reflect the economics
of the transferred liabilities. NAIC staff has instead supported asymmetrical
treatment, whereby derecognized positive IMR increases the collateral
requirement but derecognized negative IMR does not affect it, reflecting the
view that negative IMR does not constitute a transferable collateral asset;
notably, this issue is distinct from whether the ceding insurer admits the
negative IMR. The American Academy of Actuaries has proposed a potential
compromise that would permit negative IMR in the collateral calculation if the
ceding insurer can demonstrate (e.g., through asset adequacy analysis) that
collateral remains sufficient under moderately adverse scenarios.
The matter has been referred to the Reinsurance (E) Task Force, and further
action has been deferred pending its response.
Next Steps
Insurers should analyze the exposed changes to IMR guidance as they consider
portfolio rebalancing and reinsurance transactions.
Commitments and Contingencies
In response to industry inquiries and regulator comments and
directions, SAPWG developed and exposed Agenda Item 2025-24 on disclosures about commitments and
contingencies, including contingent commitments, at the NAIC 2025 Fall National
Meeting. Although information about commitments, contingent commitments, and
contingencies is provided in various footnote disclosures and on investment
schedules, regulators noted difficulty in understanding the full picture of current
and potential future obligations affecting insurers.
This is especially true for investment-related commitments. For example, Schedule BA
includes a column for “Commitment for Additional Investment,” yet Schedule D does
not. As insurers increasingly enter into complex investments, the future commitments
contained in these transactions are often not recognized as liabilities until the
commitments are called. Regulators wish to obtain full transparency of these
commitments since they can affect insurers’ liquidity and risk profiles.
At the NAIC 2026 Spring National Meeting, SAPWG deferred action on Agenda Item
2025-24 and did not discuss the agenda item in depth. However, SAPWG directed NAIC
staff to develop (1) a formal definition of commitments for incorporation within
SSAP No. 58 and (2) a new comprehensive commitments and contingent commitments disclosure.
Currently, definitions of liabilities, commitments, and contingencies under
statutory accounting guidance are consistent with those under U.S. GAAP. Interested
parties have expressed concern about the potential for inconsistency between the
accounting bases and the unintended consequences of such disclosure.
Although the extent to which additional disclosure will be required is currently
unknown, insurers should monitor the status of Agenda Item 2025-24 and, in the case
of investment-related commitments, ensure that they have access to all necessary
information to disclose commitments on a security-by-security basis on Schedule
D.
Equity Method Investments in Entities Other Than Subsidiary, Controlled, and Affiliated Entities
Agenda Item 2025-26 on reporting equity changes related to
investments within the scope of SSAP No. 489 was also developed and exposed at the NAIC 2025 Fall National Meeting. SSAP
No. 48 provides the accounting requirements for using the equity method of
accounting if the insurer holds a minor ownership interest or lacks control. If
there is a more than minor ownership interest, the equity method of accounting is
applied in accordance with paragraphs 8(b)(i)–(iv) of SSAP No. 97, under which the
appropriate model for applying the equity method of accounting is determined on the
basis of the investee (e.g., insurance company, noninsurance company, foreign
insurance company). Application of the equity method of accounting under both SSAP
No. 48 and SSAP No. 9710 is based on (1) audited investee equity (sometimes under U.S. GAAP) as
adjusted for periodic unrealized gains and losses, (2) amortization of the basis
difference (i.e., goodwill), and (3) other items that are capital in nature. Upon
analyzing annual statement filings, NAIC staff noted that there were valuation
changes reported on Schedule BA that could not be explained only through review of
that schedule. Thus, SAPWG is seeking more information from industry
representatives.
Although no revisions were proposed at the NAIC 2026 Spring National Meeting, Agenda
Item 2025-26 requests comments on various aspects of the equity method of
accounting, including (1) the timing of recognition of equity value increases and
declines, (2) goodwill and negative goodwill, (3) income recognition, (4)
impairment, and (5) disclosures on Schedule BA.
With the goal of clarified guidance and consistent application, SAPWG directed NAIC
staff to organize a limited industry focus group to assist in the development of
proposed revisions. There are many disparate types of investments that fall within
the scope of SSAP No. 48. In preparation for potential changes to guidance, insurers
should ensure that they have a full and complete picture of their equity method
investment portfolio, including the impact of the equity method of accounting on
financial reporting and risk-based capital.
Contacts
If you have questions about this publication, please contact the following Deloitte
professionals:
|
Andrew Pidgeon
Audit & Assurance
Partner
Deloitte & Touche LLP
+1 415 783 6426
|
Bala Bellur
Audit & Assurance
Managing Director
Deloitte & Touche LLP
+1 813 769 3210
| ||
|
Josh Martin
Audit & Assurance
Managing Director
Deloitte & Touche LLP
+1 860 725 3153
|
John Tittle
Audit & Assurance
Specialist
Deloitte & Touche LLP
+1 312 486 5486
|
Footnotes
1
NAIC Statement of Statutory Accounting Principles (SSAP) No. 86,
Derivatives.
2
NAIC Statement of Statutory Accounting Principles No. 108, Derivatives
Hedging Variable Annuity Guarantees.
3
NAIC Proposed Statement of Statutory Accounting Principles
No. 109, Asset Liability Management (ALM) Derivatives.
4
NAIC Statement of Statutory Accounting Principles No. 7,
Asset Valuation Reserve and Interest Maintenance Reserve.
5
NAIC Proposed Statement of Statutory Accounting Principles
No. 7 (Revised), Asset Valuation Reserve and Interest Maintenance
Reserve.
6
Interpretation of the Statutory Accounting Principles (E) Working Group
No. 23-01, Net Negative (Disallowed) Interest Maintenance
Reserve.
7
NAIC Statement of Statutory Accounting Principles No. 61, Life,
Deposit-Type and Accident and Health Reinsurance.
8
NAIC Statement of Statutory Accounting Principles No. 5, Liabilities,
Contingencies and Impairments of Assets.
9
NAIC Statement of Statutory Accounting Principles No. 48, Joint Ventures,
Partnerships and Limited Liability Companies.
10
NAIC Statement of Statutory Accounting Principles No. 97, Investments in
Subsidiary, Controlled and Affiliated Entities.